Postmarketing Surveillance Data Conclusions (cont.)

• Literature suggests individuals > 65 years of age may be at an increased risk for developing psychiatric disorders and CNS AEs due to the drug’s anticholinergic side-effects

Previous slide

Back to first slide

View graphic version